MX9301882A - Derivados de imidazol, su procedimiento de preparacion y su aplicacion en terapeutica. - Google Patents
Derivados de imidazol, su procedimiento de preparacion y su aplicacion en terapeutica.Info
- Publication number
- MX9301882A MX9301882A MX9301882A MX9301882A MX9301882A MX 9301882 A MX9301882 A MX 9301882A MX 9301882 A MX9301882 A MX 9301882A MX 9301882 A MX9301882 A MX 9301882A MX 9301882 A MX9301882 A MX 9301882A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation procedure
- therapeutics
- imidazole
- derivatives
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/62—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR929203944A FR2689508B1 (fr) | 1992-04-01 | 1992-04-01 | Derives de l'imidazole, leur procede de preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9301882A true MX9301882A (es) | 1994-06-30 |
Family
ID=9428340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9301882A MX9301882A (es) | 1992-04-01 | 1993-04-01 | Derivados de imidazol, su procedimiento de preparacion y su aplicacion en terapeutica. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0564356A1 (forum.php) |
| JP (1) | JPH06263743A (forum.php) |
| KR (1) | KR930021622A (forum.php) |
| CN (1) | CN1081438A (forum.php) |
| AU (1) | AU3554693A (forum.php) |
| CA (1) | CA2092852A1 (forum.php) |
| FI (1) | FI931414A7 (forum.php) |
| FR (1) | FR2689508B1 (forum.php) |
| HU (1) | HUT64752A (forum.php) |
| MX (1) | MX9301882A (forum.php) |
| NO (1) | NO931186L (forum.php) |
| TW (1) | TW232012B (forum.php) |
| ZA (1) | ZA932351B (forum.php) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015817A (en) * | 1996-12-05 | 2000-01-18 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| UA71587C2 (uk) * | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
| DE10023486C1 (de) * | 2000-05-09 | 2002-03-14 | Schering Ag | Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel |
| WO2003006012A1 (en) * | 2001-07-11 | 2003-01-23 | Yale University | Compounds and methods for the inhibition of trypanosoma cruz i |
| US7615565B2 (en) | 2002-07-31 | 2009-11-10 | Bayer Schering Pharma Aktiengesellschaft | VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
| UA89035C2 (ru) | 2003-12-03 | 2009-12-25 | Лео Фарма А/С | Эфиры гидроксамовых кислот и их фармацевтическое применение |
| EP1655295A1 (en) | 2004-11-03 | 2006-05-10 | Schering Aktiengesellschaft | Anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| EP1657241A1 (en) | 2004-11-03 | 2006-05-17 | Schering Aktiengesellschaft | Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| US7906533B2 (en) | 2004-11-03 | 2011-03-15 | Bayer Schering Pharma Ag | Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| EP1752450A1 (en) | 2005-08-01 | 2007-02-14 | Merck Sante | Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| MX2009012755A (es) | 2007-05-24 | 2010-04-30 | Eldrug S A | Imidazoles 1,(3,)5-substituidos, su uso en el tratamiento de hipertension y metodos para su preparacion. |
| GR1006917B (el) * | 2007-10-24 | 2010-07-30 | Ελληνικα Φαρμακα Ερευνα Και Αναπτυξη Eldrug Α.Ε., | Ανταγωνιστες του υποδοχεα της αγγειοτενσινης ιι με βαση την ισταμινη (και παραγωγα αυτης) με ιδιοτητες καταστολης του συμπαθητικου συστηματος και συνθετικες μεθοδοι στη θεραπεια της υπερτασης και αλλων καρδιοαγγειακων ασθενειων. |
| EP2188279A2 (en) * | 2007-08-01 | 2010-05-26 | Eldrug S.A. | 1,3 and 1,3,5 substituted imidazoles as antihypertensiva |
| MX2011002069A (es) | 2008-08-27 | 2011-06-20 | Leo Pharma As | Derivados de piridina como receptores vegfr-2 e inhibidores de la proteina tirosina cinasa. |
| CN102584709B (zh) * | 2011-12-19 | 2016-08-17 | 浙江华海药业股份有限公司 | 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺 |
| JP7197880B2 (ja) * | 2017-10-19 | 2022-12-28 | 学校法人 名城大学 | エステル化剤及びその利用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2110663B (en) * | 1981-12-04 | 1985-08-07 | Farmos Group Ltd | Imidazole derivatives |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| EP0955294B1 (en) * | 1989-06-14 | 2003-09-24 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid |
| EP0403158A3 (en) * | 1989-06-14 | 1991-12-18 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| AU640417B2 (en) * | 1989-10-25 | 1993-08-26 | Smithkline Beecham Corporation | Substituted 5-((tetrazolyl)alkenyl)imidazoles |
| CA2028925A1 (en) * | 1989-11-06 | 1991-05-07 | Gerald R. Girard | Substituted n-(imidazolyl)alkyl alanine derivatives |
| GB8927928D0 (en) * | 1989-12-11 | 1990-02-14 | Roussel Lab Ltd | Chemical compounds |
| NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
-
1992
- 1992-04-01 FR FR929203944A patent/FR2689508B1/fr not_active Expired - Fee Related
-
1993
- 1993-03-24 TW TW082102193A patent/TW232012B/zh active
- 1993-03-29 FI FI931414A patent/FI931414A7/fi not_active Application Discontinuation
- 1993-03-29 CA CA002092852A patent/CA2092852A1/en not_active Abandoned
- 1993-03-29 AU AU35546/93A patent/AU3554693A/en not_active Abandoned
- 1993-03-30 NO NO93931186A patent/NO931186L/no unknown
- 1993-03-31 KR KR1019930005246A patent/KR930021622A/ko not_active Withdrawn
- 1993-03-31 EP EP93400833A patent/EP0564356A1/fr not_active Withdrawn
- 1993-03-31 HU HU9300942A patent/HUT64752A/hu unknown
- 1993-03-31 JP JP5095158A patent/JPH06263743A/ja active Pending
- 1993-04-01 ZA ZA932351A patent/ZA932351B/xx unknown
- 1993-04-01 MX MX9301882A patent/MX9301882A/es unknown
- 1993-04-01 CN CN93104521A patent/CN1081438A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2689508B1 (fr) | 1994-06-17 |
| HU9300942D0 (en) | 1993-06-28 |
| FI931414A0 (fi) | 1993-03-29 |
| JPH06263743A (ja) | 1994-09-20 |
| EP0564356A1 (fr) | 1993-10-06 |
| AU3554693A (en) | 1993-10-07 |
| HUT64752A (en) | 1994-02-28 |
| NO931186L (no) | 1993-10-04 |
| CA2092852A1 (en) | 1993-10-02 |
| FR2689508A1 (fr) | 1993-10-08 |
| CN1081438A (zh) | 1994-02-02 |
| NO931186D0 (no) | 1993-03-30 |
| KR930021622A (ko) | 1993-11-22 |
| TW232012B (forum.php) | 1994-10-11 |
| FI931414L (fi) | 1993-10-02 |
| ZA932351B (en) | 1994-10-03 |
| FI931414A7 (fi) | 1993-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9301882A (es) | Derivados de imidazol, su procedimiento de preparacion y su aplicacion en terapeutica. | |
| ATE153855T1 (de) | Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten | |
| MX9307940A (es) | Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen | |
| ES2157337T3 (es) | Derivados de morfolina y su uso como agentes terapeuticos. | |
| CA2256582A1 (en) | Oxa acids and related compounds for treating skin conditions | |
| PT939627E (pt) | Pentafluorobenzenossulfonamidas e analogos | |
| EA199800563A1 (ru) | Антагонисты гормона, высвобождающего гонадотропин | |
| DE60037597D1 (de) | Imidazol- Derivate | |
| PL350123A1 (en) | Tetrahydropyran derivatives and their use as therapeutic agents | |
| TR199800436A2 (xx) | Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�. | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| DE69523155D1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| EE03003B1 (et) | Angiotensiin II retseptorite antagonistidena toimivad triasolopürimidiinide derivaadid, ravimvormid, nende valmistamise meetodid | |
| ES2110260T3 (es) | Androstenonas. | |
| IT1255802B (it) | Derivati imidazolici ad attivita' a ii antagonista | |
| ES2155827T3 (es) | 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico. | |
| KR900700495A (ko) | 치료제로서 유용한 치환된 아데닌 유도체 | |
| MX9205792A (es) | Derivados novedosos de asa-androstan 178-substituidos | |
| DE69530988D1 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| DK1242410T3 (da) | Nye forbindelser | |
| BR9709556A (pt) | Dihidrobenzopirano e compostos a ele relacionados úteis como agentes antiflamatórios | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| ES2072536T3 (es) | Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica. | |
| IT1254521B (it) | Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare | |
| BR9508436A (pt) | Dihidro benzofurando e compostos correlacionados úteis como agentes anti-inflamatórios |